Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease

MCG Stevens; N Bouvet; C Ellershaw; F Flamant; JL Habrand; HB Marsden; H Martelli; O Oberlin; A Rey; J Sanchez de Toledo; RD Spicer; D Spooner; MJ Terrier-Lacombe; A Van Unnik

doi:10.1016/j.ejca.2007.12.007

Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease

MCG Stevens, N Bouvet, C Ellershaw, F Flamant, JL Habrand, HB Marsden, H Martelli, O Oberlin, A Rey, J Sanchez de Toledo, RD Spicer, D Spooner, MJ Terrier-Lacombe, A Van Unnik

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

29 Citations (Scopus)

Translated title of the contribution	Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease
Original language	English
Pages (from-to)	427 - 431
Number of pages	5
Journal	European Journal of Cancer
Volume	44
DOIs	https://doi.org/10.1016/j.ejca.2007.12.007
Publication status	Published - Feb 2008

Bibliographical note

Publisher: Elsevier
Other: Key Words: Doxorubicin, Rhabdomyosarcoma, Children

Access to Document

10.1016/j.ejca.2007.12.007

Handle.net

Persistent link

Cite this

Stevens, MCG., Bouvet, N., Ellershaw, C., Flamant, F., Habrand, JL., Marsden, HB., Martelli, H., Oberlin, O., Rey, A., Sanchez de Toledo, J., Spicer, RD., Spooner, D., Terrier-Lacombe, MJ., & Van Unnik, A. (2008). Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease. European Journal of Cancer, 44, 427 - 431. https://doi.org/10.1016/j.ejca.2007.12.007

@article{d84a4b003b044d6d8b52ffea9ef4678a,

title = "Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease",

author = "MCG Stevens and N Bouvet and C Ellershaw and F Flamant and JL Habrand and HB Marsden and H Martelli and O Oberlin and A Rey and {Sanchez de Toledo}, J and RD Spicer and D Spooner and MJ Terrier-Lacombe and {Van Unnik}, A",

note = "Publisher: Elsevier Other: Key Words: Doxorubicin, Rhabdomyosarcoma, Children",

year = "2008",

month = feb,

doi = "10.1016/j.ejca.2007.12.007",

language = "English",

volume = "44",

pages = "427 -- 431",

journal = "European Journal of Cancer",

issn = "0014-2964",

publisher = "European School of Oncology (ESO)",

}

Stevens, MCG, Bouvet, N, Ellershaw, C, Flamant, F, Habrand, JL, Marsden, HB, Martelli, H, Oberlin, O, Rey, A, Sanchez de Toledo, J, Spicer, RD, Spooner, D, Terrier-Lacombe, MJ & Van Unnik, A 2008, 'Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease', European Journal of Cancer, vol. 44, pp. 427 - 431. https://doi.org/10.1016/j.ejca.2007.12.007

TY - JOUR

T1 - Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease

AU - Stevens, MCG

AU - Bouvet, N

AU - Ellershaw, C

AU - Flamant, F

AU - Habrand, JL

AU - Marsden, HB

AU - Martelli, H

AU - Oberlin, O

AU - Rey, A

AU - Sanchez de Toledo, J

AU - Spicer, RD

AU - Spooner, D

AU - Terrier-Lacombe, MJ

AU - Van Unnik, A

N1 - Publisher: Elsevier Other: Key Words: Doxorubicin, Rhabdomyosarcoma, Children

PY - 2008/2

Y1 - 2008/2

U2 - 10.1016/j.ejca.2007.12.007

DO - 10.1016/j.ejca.2007.12.007

M3 - Article (Academic Journal)

C2 - 18215514

VL - 44

SP - 427

EP - 431

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0014-2964

ER -